ACORN CAPITAL ADVISORS, LLC
Q4 2025 13F Holdings
- Locationnew york, NY
- Num holdings
21
- Value ($000)
$295,133
- Date Filed02/17/2026
- Form type13F-HR
- CIK0002054410
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
TERNS PHARMACEUTICALS INC | COM | 880881107 | $70.55M | 24 % | 1,746,264 | ||
CG ONCOLOGY INC | COM | 156944100 | $46.98M | 16 % | 1,131,501 | ||
UROGEN PHARMA LTD | COM | M96088105 | $33.92M | 12 % | 1,448,420 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | $26.85M | 9 % | 2,144,844 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | $24.58M | 8 % | 4,131,299 | ||
CANDEL THERAPEUTICS INC | COM | 137404109 | $14.58M | 5 % | 2,580,517 | ||
CYBIN INC | COM NEW | 23256X407 | $12.87M | 4 % | 1,573,023 | ||
VERASTEM INC | COM | 92337C203 | $11.34M | 4 % | 1,469,153 | ||
BICARA THERAPEUTICS | COM | 055477103 | $10.83M | 4 % | 643,382 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | $9.34M | 3 % | 1,752,115 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100